IRCSS Giovanni Paolo II
Dr. Angelo Virgilio Paradiso
“Giovanni Paolo II” is a Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), a legal entity of public law, of national relevance, not transformed into a foundation, confirmed by Ministerial Decree May 30, 2014, published in the Official Gazette No. 140 of 19-6-2014, in the disciplinary specialization Oncology.
The Institute stands as a center of excellence for pre-clinical, translational, and clinical research and assistance. Inseparability, reciprocity, and the functional continuum between clinical and research constitute an added value of undoubtedly positive significance, earning the certification as a Clinical Cancer Center (February 12, 2015), following the provisions of the Organization of European Cancer Institutes (OECI).
It is equipped with 109 beds to treat all adult oncological diseases.
It employs 110 researchers (2018).
The Institute is equipped with several laboratories dedicated explicitly to research (Invasion and Metastasis, Applied Molecular Genetics, Clinical and Pre-clinical Pharmacology, Functional Bio-morphology).
It is also equipped with a GMP – Facility (Advanced Cellular Therapy Center) and a Biobank representing the infrastructure dedicated to the CRYOPRESERVATION and HANDLING of biological tissue, cellular and serum samples used following national and international guidelines and for scientific research purposes.
Among the technological and clinical equipment in the Institute, the UMACA Laboratory and a Hybrid Operating Room designed for the most modern radiotherapy-interventional applications stand out.
Consult the individual files of our Members